Author

Matthew Waldbrook

Xenon Pharmaceuticals (Canada)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Arjun Mahadevan· 1 shared Janette Mezeyova· 1 shared Maegan Soriano· 1 shared Pareesa Versi· 1 shared R. Ryley ParrishiD· 1 shared Samrat ThoutaiD· 1 shared Samuel J. GoodchildiD· 1 shared Sophia Lin· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Arjun Mahadevan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacological determination of the fractional block of Nav channels required to impair neuronal excitability and ex vivo seizures

Samrat Thouta, Matthew Waldbrook, Sophia Lin, Arjun Mahadevan, Janette Mezeyova, Maegan Soriano, Pareesa Versi, Samuel J. Goodchild, R. Ryley Parrish

The paper determines the fractional block of Nav channels needed to impair neuronal excitability and reduce seizure-like activity using TTX in pyramidal neurons.

Frontiers in Cellular Neuroscience · Sep 29, 2022Peer-reviewedNeuroscience